Protherics PLC -Total Voting Rights

* Reuters is not responsible for the content in this press release.

Tue Sep 2, 2008 7:13am EDT 

  CHESHIRE, UK, Sep 02 (MARKET WIRE) -- 

Protherics PLC

Total Voting Rights and Share Capital

London, UK; Brentwood, TN; 2 September 2008 - In conformity with the
Transparency Directive, Protherics PLC ("Protherics"), the
international biopharmaceutical company focused on critical care and
cancer, notifies the market of the following:

Protherics' issued share capital consists of
342,203,934 ordinary shares with a nominal value of 2 pence each, with
voting rights. Protherics does not hold any ordinary shares in
Treasury.  Therefore, the total number of voting rights
in Protherics is 342,203,934.

The above figure may be used by shareholders as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest
in, Protherics under the Financial Services Authority's Disclosure and
Transparency Rules.

/ Ends /

For further information please contact:

Protherics

Nick Staples, Director of Corporate Affairs   +44 (0) 7919 480510

Julie Vickers, Company Secretary              +44 (0)1928 518010

Financial Dynamics - press enquiries

London: Ben Atwell, Lara Mott                 +44 (0) 20 7831 3113 

New York: John Capodanno                      +1 212 850 5600

Or visit  www.protherics.com

                    This information is provided by RNS
          The company news service from the London Stock Exchange

END

    


Contacts:
RNS
Customer
Services
0044-207797-4400
Email Contact
http://www.rns.com

Copyright 2008, Market Wire, All rights reserved.

-0-
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.